Skip to content

What is Peptide Therapy? A Complete Map

Peptide therapy refers to a set of protocols that use exogenous peptides for targeted physiological regulation, covering target selection, quality control, administration routes, and cycle assessment. It is neither a single drug nor a common supplement; this page maps the five major directions, how a protocol runs, and the safety and regulatory boundaries.

Category Nature Related Pages
Peptide therapy (research/protocol-oriented) Exogenous peptide regulation, mechanism- and practice-focused This page and the whole site
Drugs (e.g. GLP-1 receptor agonists) Prescription drugs, regulatory approval paths GLP-1 head-to-head review
Nutritional peptides (collagen peptides, whey peptides) Food grade, nutritional support Oral nutraceutical peptides
Cosmetic peptides (topical) Skincare ingredients, local action Cosmeceutical peptides

All four share the word “peptide”, but their evidence standards, regulatory paths, and risk structures are completely different. For the conceptual base, see Peptide Basics.

Direction Typical Agents Discussion Context Deep-Dive Pages
Repair and regeneration BPC-157, TB-500 Tendons, ligaments, scars, nerves BPC-157, TB-500
Metabolism and weight GLP-1 class, Tesamorelin Weight-loss plateaus, visceral fat, muscle preservation GLP-1 head-to-head review, weight-loss peptides
Cognition and mood Semax, Selank Brain fog, anxiety, focus Semax & Selank, nootropic peptides
Skincare and hair GHK-Cu, signal peptides Post-procedure repair, collagen, barrier copper peptides, cosmeceutical peptides
Longevity and mitochondria Epithalon, MOTS-c, SS-31 Cellular senescence, mitochondria longevity trio

Each direction has matching symptom-scenario pages on the site (sports recovery, metabolism, cognition and sleep, skin) — enter by problem, search by agent.

  1. Pick the target: symptom/goal → choose the agent from the ingredient encyclopedia; only when the mechanism matches do you move on.
  2. Control quality: COA / HPLC / MS — batch number, purity, salt form, and content are the baseline; defusing fake reports is routine work.
  3. Reconstitute: for lyophilized powder, BAC water, concentration conversions, and IU markings.
  4. Choose the route: SubQ, nasal, oral, and transdermal — the same peptide behaves differently by route, with different bioavailability.
  5. Manage the cycle: storage and cold chain, onset evaluation, review and adjust.
  • Regulations differ widely: the same agent may be a prescription drug, a research reagent, or a gray area depending on the country/region — check local rules before you start.
  • Evidence is uneven: from in vitro and animal work to small human samples and formulation observations, the chain length varies; “there is research” is not “there is a conclusion”.
  • Quality risk: agents without a batch number or test reports are at your own risk; quality-control steps are covered in the practical guide.
Evidence Tier What It Means How to Use It
In vitro / mechanism Cellular and pathway level Explains “how it might work”, does not predict human effects
Animal studies Effective in a model Directional reference; doses need conversion, extrapolate cautiously
Small human samples Preliminary signals Watch endpoint measures and control design
Formulation / protocol observations Real-use records Many variables, easily confounded by vehicle and combinations

The “Key References” and “Evidence Notes” sections across the site are written to this standard; anything uncertain is flagged directly.